APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next-Generation Sequencing eDNA Biomonitoring

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Next-Generation Sequencing eDNA Biomonitoring Market Outlook and Growth Opportunities 2026

Report ID 174197330416 April 2026Not stated

Choose your research edition.

Industry ResearchNext-Generation Sequencing eDNA Biomonitoring Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Next-Generation Sequencing eDNA Biomonitoring Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Next-Generation Sequencing eDNA Biomonitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next-Generation Sequencing eDNA Biomonitoring Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Next-Generation Sequencing eDNA Biomonitoring Market Analysis and Forecast 2026-2032259 pages · $4,950 USD

Market perspective

The global Next-Generation Sequencing eDNA Biomonitoring market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Next-Generation Sequencing eDNA Biomonitoring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next-Generation Sequencing eDNA Biomonitoring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next-Generation Sequencing eDNA Biomonitoring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Next-Generation Sequencing eDNA Biomonitoring market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Next-Generation Sequencing eDNA Biomonitoring market include Illumina, Inc, Stantec, Eurofins Genomics, Spygen, ID-Gene Ecordiagnostics, EnviroDNA, eDNAtec, Genidaqs and NatureMetrics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Next-Generation Sequencing eDNA Biomonitoring market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next-Generation Sequencing eDNA Biomonitoring and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next-Generation Sequencing eDNA Biomonitoring revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next-Generation Sequencing eDNA Biomonitoring market.

Next-Generation Sequencing eDNA Biomonitoring Segment by Company

Illumina, Inc

Stantec

Eurofins Genomics

Spygen

ID-Gene Ecordiagnostics

EnviroDNA

eDNAtec

Genidaqs

NatureMetrics

Jonah Ventures

Sinsoma GmbH

SimplexDNA

Next-Generation Sequencing eDNA Biomonitoring Segment by Type

Targeted Sequencing & Resequencing

Whole Genome Sequencing

Whole Exome Sequencing

Next-Generation Sequencing eDNA Biomonitoring Segment by Application

Water

Soil

Air

Others

Next-Generation Sequencing eDNA Biomonitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Next-Generation Sequencing eDNA Biomonitoring status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Next-Generation Sequencing eDNA Biomonitoring key companies, revenue, market share, and recent developments.

3. To split the Next-Generation Sequencing eDNA Biomonitoring breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Next-Generation Sequencing eDNA Biomonitoring market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next-Generation Sequencing eDNA Biomonitoring significant trends, drivers, influence factors in global and regions.

6. To analyze Next-Generation Sequencing eDNA Biomonitoring competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing eDNA Biomonitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing eDNA Biomonitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing eDNA Biomonitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing eDNA Biomonitoring industry.

Chapter 3: Detailed analysis of Next-Generation Sequencing eDNA Biomonitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Next-Generation Sequencing eDNA Biomonitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Next-Generation Sequencing eDNA Biomonitoring in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next-Generation Sequencing eDNA Biomonitoring Industry Trends Table 2. Next-Generation Sequencing eDNA Biomonitoring Industry Drivers Table 3. Next-Generation Sequencing eDNA Biomonitoring Industry Opportunities and Challenges Table 4. Next-Generation Sequencing eDNA Biomonitoring Industry Restraints Table 5. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Share by Company (2021-2026) Table 7. Global Next-Generation Sequencing eDNA Biomonitoring Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Next-Generation Sequencing eDNA Biomonitoring Key Company Manufacturing Base & Headquarters Table 9. Global Next-Generation Sequencing eDNA Biomonitoring Company, Product Type & Application Table 10. Global Next-Generation Sequencing eDNA Biomonitoring Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Next-Generation Sequencing eDNA Biomonitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Sequencing & Resequencing Table 15. Significant Companies of Whole Genome Sequencing Table 16. Significant Companies of Whole Exome Sequencing Table 17. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type (2021-2026) Table 21. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Water Table 23. Significant Companies of Soil Table 24. Significant Companies of Air Table 25. Significant Companies of Others Table 26. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application (2021-2026) Table 30. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application (2027-2032) Table 31. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Region (2021-2026) Table 34. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Region (2027-2032) Table 36. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Market Share by Country (2021-2026) Table 39. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Market Share by Country (2027-2032) Table 41. Illumina, Inc Company Information Table 42. Illumina, Inc Business Overview Table 43. Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 45. Illumina, Inc Recent Development Table 46. Stantec Company Information Table 47. Stantec Business Overview Table 48. Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Stantec Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 50. Stantec Recent Development Table 51. Eurofins Genomics Company Information Table 52. Eurofins Genomics Business Overview Table 53. Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 55. Eurofins Genomics Recent Development Table 56. Spygen Company Information Table 57. Spygen Business Overview Table 58. Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Spygen Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 60. Spygen Recent Development Table 61. ID-Gene Ecordiagnostics Company Information Table 62. ID-Gene Ecordiagnostics Business Overview Table 63. ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 65. ID-Gene Ecordiagnostics Recent Development Table 66. EnviroDNA Company Information Table 67. EnviroDNA Business Overview Table 68. EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 70. EnviroDNA Recent Development Table 71. eDNAtec Company Information Table 72. eDNAtec Business Overview Table 73. eDNAtec Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. eDNAtec Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 75. eDNAtec Recent Development Table 76. Genidaqs Company Information Table 77. Genidaqs Business Overview Table 78. Genidaqs Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Genidaqs Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 80. Genidaqs Recent Development Table 81. NatureMetrics Company Information Table 82. NatureMetrics Business Overview Table 83. NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 85. NatureMetrics Recent Development Table 86. Jonah Ventures Company Information Table 87. Jonah Ventures Business Overview Table 88. Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 90. Jonah Ventures Recent Development Table 91. Sinsoma GmbH Company Information Table 92. Sinsoma GmbH Business Overview Table 93. Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 95. Sinsoma GmbH Recent Development Table 96. SimplexDNA Company Information Table 97. SimplexDNA Business Overview Table 98. SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Product Portfolio Table 100. SimplexDNA Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Next-Generation Sequencing eDNA Biomonitoring Product Image Figure 2. Global Next-Generation Sequencing eDNA Biomonitoring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next-Generation Sequencing eDNA Biomonitoring Market Size (2021-2032) & (US$ Million) Figure 4. Global Next-Generation Sequencing eDNA Biomonitoring Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Sequencing & Resequencing Image Figure 8. Whole Genome Sequencing Image Figure 9. Whole Exome Sequencing Image Figure 10. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type (2021-2032) Figure 13. Water Image Figure 14. Soil Image Figure 15. Air Image Figure 16. Others Image Figure 17. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application (2021-2032) Figure 20. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032) & (US$ Million) Figure 23. North America Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032) & (US$ Million) Figure 29. South America Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing & Resequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
Applications
  • Water
  • Soil
  • Air
  • Others
Companies covered
  • Illumina, Inc
  • Stantec
  • Eurofins Genomics
  • Spygen
  • ID-Gene Ecordiagnostics
  • EnviroDNA
  • eDNAtec
  • Genidaqs
  • NatureMetrics
  • Jonah Ventures
  • Sinsoma GmbH
  • SimplexDNA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Next-Generation Sequencing eDNA Biomonitoring Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Next-Generation Sequencing eDNA Biomonitoring Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Next-Generation Sequencing eDNA Biomonitoring Market Dynamics
  1. 2.1 Next-Generation Sequencing eDNA Biomonitoring Industry Trends
  2. 2.2 Next-Generation Sequencing eDNA Biomonitoring Industry Drivers
  3. 2.3 Next-Generation Sequencing eDNA Biomonitoring Industry Opportunities and Challenges
  4. 2.4 Next-Generation Sequencing eDNA Biomonitoring Industry Restraints
3 Next-Generation Sequencing eDNA Biomonitoring Market by Company
  1. 3.1 Global Next-Generation Sequencing eDNA Biomonitoring Company Revenue Ranking in 2025
  2. 3.2 Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Company (2021-2026)
  3. 3.3 Global Next-Generation Sequencing eDNA Biomonitoring Company Ranking (2024-2026)
  4. 3.4 Global Next-Generation Sequencing eDNA Biomonitoring Company Manufacturing Base and Headquarters
  5. 3.5 Global Next-Generation Sequencing eDNA Biomonitoring Company Product Type and Application
  6. 3.6 Global Next-Generation Sequencing eDNA Biomonitoring Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Next-Generation Sequencing eDNA Biomonitoring Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Next-Generation Sequencing eDNA Biomonitoring Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Next-Generation Sequencing eDNA Biomonitoring Market by Type
  1. 4.1 Next-Generation Sequencing eDNA Biomonitoring Type Introduction
  2. 4.1.1 Targeted Sequencing & Resequencing
  3. 4.1.2 Whole Genome Sequencing
  4. 4.1.3 Whole Exome Sequencing
  5. 4.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type
  6. 4.2.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Type (2021-2032)
  8. 4.2.3 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type (2021-2032)
5 Next-Generation Sequencing eDNA Biomonitoring Market by Application
  1. 5.1 Next-Generation Sequencing eDNA Biomonitoring Application Introduction
  2. 5.1.1 Water
  3. 5.1.2 Soil
  4. 5.1.3 Air
  5. 5.1.4 Others
  6. 5.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application
  7. 5.2.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Application (2021-2032)
  9. 5.2.3 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application (2021-2032)
6 Next-Generation Sequencing eDNA Biomonitoring Regional Value Analysis
  1. 6.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region (2021-2032)
  3. 6.2.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region: 2021-2026
  4. 6.2.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032)
  7. 6.3.2 North America Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032)
  10. 6.4.2 Europe Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032)
  16. 6.6.2 South America Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Country, 2025 VS 2032
7 Next-Generation Sequencing eDNA Biomonitoring Country-level Value Analysis
  1. 7.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country (2021-2032)
  3. 7.2.1 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country (2021-2026)
  4. 7.2.2 Global Next-Generation Sequencing eDNA Biomonitoring Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Next-Generation Sequencing eDNA Biomonitoring Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina, Inc
  2. 8.1.1 Illumina, Inc Company Information
  3. 8.1.2 Illumina, Inc Business Overview
  4. 8.1.3 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  6. 8.1.5 Illumina, Inc Recent Developments
  7. 8.2 Stantec
  8. 8.2.1 Stantec Company Information
  9. 8.2.2 Stantec Business Overview
  10. 8.2.3 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Stantec Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  12. 8.2.5 Stantec Recent Developments
  13. 8.3 Eurofins Genomics
  14. 8.3.1 Eurofins Genomics Company Information
  15. 8.3.2 Eurofins Genomics Business Overview
  16. 8.3.3 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  18. 8.3.5 Eurofins Genomics Recent Developments
  19. 8.4 Spygen
  20. 8.4.1 Spygen Company Information
  21. 8.4.2 Spygen Business Overview
  22. 8.4.3 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Spygen Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  24. 8.4.5 Spygen Recent Developments
  25. 8.5 ID-Gene Ecordiagnostics
  26. 8.5.1 ID-Gene Ecordiagnostics Company Information
  27. 8.5.2 ID-Gene Ecordiagnostics Business Overview
  28. 8.5.3 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  30. 8.5.5 ID-Gene Ecordiagnostics Recent Developments
  31. 8.6 EnviroDNA
  32. 8.6.1 EnviroDNA Company Information
  33. 8.6.2 EnviroDNA Business Overview
  34. 8.6.3 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  35. 8.6.4 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  36. 8.6.5 EnviroDNA Recent Developments
  37. 8.7 eDNAtec
  38. 8.7.1 eDNAtec Company Information
  39. 8.7.2 eDNAtec Business Overview
  40. 8.7.3 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  41. 8.7.4 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  42. 8.7.5 eDNAtec Recent Developments
  43. 8.8 Genidaqs
  44. 8.8.1 Genidaqs Company Information
  45. 8.8.2 Genidaqs Business Overview
  46. 8.8.3 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  48. 8.8.5 Genidaqs Recent Developments
  49. 8.9 NatureMetrics
  50. 8.9.1 NatureMetrics Company Information
  51. 8.9.2 NatureMetrics Business Overview
  52. 8.9.3 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  54. 8.9.5 NatureMetrics Recent Developments
  55. 8.10 Jonah Ventures
  56. 8.10.1 Jonah Ventures Company Information
  57. 8.10.2 Jonah Ventures Business Overview
  58. 8.10.3 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  60. 8.10.5 Jonah Ventures Recent Developments
  61. 8.11 Sinsoma GmbH
  62. 8.11.1 Sinsoma GmbH Company Information
  63. 8.11.2 Sinsoma GmbH Business Overview
  64. 8.11.3 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  66. 8.11.5 Sinsoma GmbH Recent Developments
  67. 8.12 SimplexDNA
  68. 8.12.1 SimplexDNA Company Information
  69. 8.12.2 SimplexDNA Business Overview
  70. 8.12.3 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Product Portfolio
  72. 8.12.5 SimplexDNA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst